Cartesian Therapeutics In... (RNAC)
17.58
-1.26 (-6.69%)
At close: Mar 03, 2025, 3:59 PM
17.50
-0.46%
After-hours: Mar 03, 2025, 04:00 PM EST
Cartesian Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Revenue | 26M | 110.78M | 85.08M | 16.6M | 6.68M | 903K | 207K | 8.08M | 6.01M | 3.04M |
| Cost of Revenue | 1.55M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 24.45M | 108.74M | 85.08M | 16.6M | 6.68M | 903K | 207K | 8.08M | 6.01M | 3.04M |
| Operating Income | -86.42M | 14.54M | -4.6M | -56.82M | -52.45M | -65.02M | -63.78M | -34.67M | -25.3M | -15.4M |
| Interest Income | n/a | n/a | n/a | n/a | 834K | 1.05M | 617K | 234K | 171K | 111K |
| Pretax Income | -238.71M | 34.77M | -9.72M | -68.88M | -55.35M | -65.34M | -65.32M | -36.21M | -25.17M | -12.88M |
| Net Income | -219.71M | 35.38M | -25.69M | -68.88M | -55.35M | -65.34M | -65.32M | -36.21M | -25.17M | -12.88M |
| Selling & General & Admin | 40.58M | 23.86M | 20.94M | 18.91M | 14.36M | 17.26M | 18.08M | 12.25M | 7.29M | 7.95M |
| Research & Development | 71.84M | 72.38M | 68.74M | 54.51M | 42.74M | 47.69M | 45.16M | 29.7M | 22.98M | 10.49M |
| Other Expenses | n/a | 330K | 15K | 89K | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 110.87M | 96.24M | 89.67M | 73.42M | 57.1M | 64.95M | 63.24M | 41.95M | 30.27M | 18.44M |
| Interest Expense | 2.83M | 3.03M | 2.84M | 1.56M | 1.52M | 1.49M | 1.21M | 1.25M | 948K | 552K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 112.42M | 96.24M | 89.67M | 73.42M | 59.13M | 65.92M | 63.99M | 42.75M | 31.32M | 18.44M |
| Income Tax | -19M | -609K | 15.97M | 1.65M | 1.86M | 1.00 | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 5.17M | 4.83M | 3.81M | 3.37M | 1.52M | 746.31K | 680.83K | 349.8K | 621.65K | 428.95K |
| Shares Outstanding (Diluted) | 5.17M | 4.86M | 3.81M | 3.37M | 1.52M | 746.31K | 680.83K | 349.8K | 621.65K | 428.95K |
| EPS (Basic) | -42.49 | 7.33 | -6.74 | -20.42 | -36.46 | -87.55 | -95.94 | -103.52 | -40.5 | -38.17 |
| EPS (Diluted) | -42.49 | 2.98 | -6.74 | -20.42 | -36.46 | -87.55 | -95.94 | -103.52 | -40.5 | -38.17 |
| EBITDA | -235.06M | 39.84M | -5.16M | -65.59M | -51.8M | -62.87M | -63.37M | -34.16M | -23.18M | -11.46M |
| Depreciation & Amortization | 843K | 2.04M | 1.72M | 1.73M | 2.03M | 975K | 750K | 802K | 1.04M | 864K |